Lyra Therapeutics, Inc.
NASDAQ:LYRA
Overview | Financials
Company Name | Lyra Therapeutics, Inc. |
Symbol | LYRA |
Currency | USD |
Price | 0.265 |
Market Cap | 17,346,026 |
Dividend Yield | 0% |
52-week-range | 0.211 - 6.79 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Maria Palasis Ph.D. |
Website | https://lyratherapeutics.com |
An error occurred while fetching data.
About Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD